(Cluster) randomised trial | Comparing outcomes between individuals or care providers randomly assigned to receive/apply management/decisions guided by the prediction model (ie, risk-based management) versus no risk-based-management (care-as-usual) Unbiased comparisons Time consuming and expensive
| Quantifying the effects of communication of absolute cardiovascular disease risk and shared decision-making using a simple decision aid for use in family practice consultation35 |
Stepped-wedge cluster randomised trial | Comparing individuals' outcomes between clusters which first apply care-as-usual and subsequently, at randomly allocated time points, risk-based management Unbiased comparisons Useful for complex interventions that can be evaluated during implementation in routine care Time consuming and expensive
| Measure the impact of a multifaceted strategy, including a preoperative risk assessment, to prevent the occurrence of postoperative delirium in elderly surgical patients36 |
Prospective before–after study | Comparing individuals' outcomes between those treated conventionally in an earlier period and those treated in a later period after introduction of the prediction model Sensitive to potential time effects and subject differences Time consuming
| The PREDICT-CVD programme to investigate whether introduction of integrated electronic decision support based upon the Framingham absolute risk equation improves cardiovascular disease risk assessment37 |
Decision analytic modelling | Combines evidence on the accuracy of model predictions from observational model (external) validation studies, and on the effectiveness of subsequent management from randomised therapeutic trials or meta-analysis Relies on various model inputs and assumptions Less time consuming and low costs
| Predicting the impact on a population level on the incidence of CVD-related events over a 5–10-year period, using prediction models (such as the UKPDS and a derivative of the Framingham risk equation)38 |
Cross-sectional study | Comparing care providers' decisions after being randomised to either use or not use the model's predicted risk No subject outcome (no follow-up) Less time consuming and low costs
| The AVIATOR study to quantify whether global risk assessment on coronary heart disease leads to different targeted preventive treatments39 |
Before–after study within the same care providers | Care providers are asked to document therapeutic management decisions before and after being ‘exposed’ to a model's predictions No subject outcomes required (no follow-up) Less time consuming and low costs
| Effect of using 10-year and lifetime coronary risk information on preventive medication prescriptions as compared with not using these risks40 |